FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Integragen's FCF Yield % or its related term are showing as below:
XPAR:ALINT's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -9.62 * Ranked among companies with meaningful FCF Yield % only.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Integragen FCF Yield % Related Terms
Integragen FCF Yield % Historical Data
* Premium members only.
The historical data trend for Integragen's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ALINT vs VRTX, REGN, ALNY: FCF Yield % Comparison
For the Biotechnology subindustry, Integragen's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integragen FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Integragen's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Integragen's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integragen (XPAR:ALINT) has a FCF Yield % of 0.00 as of Jun. 28, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Integragen and its competitors. According to the industry distribution chart, Integragen ranks #999999 out of 1416 companies in the Biotechnology industry.
Is Integragen's FCF Yield % too high?
Integragen's current FCF Yield % is 0.00. Based on the distribution chart, Integragen ranks #999999 out of 1416 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Integragen has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Integragen's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Integragen ranks #999999 out of 1416 companies for FCF Yield %. This places Integragen in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Integragen and its competitors. Integragen's current FCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integragen stock overvalued right now?
Based on GuruFocus' analysis, Integragen (XPAR:ALINT) is currently considered Possible Value Trap. The stock's GF Value™ is €0.42, compared to a current price of €0.19 — trading 55.7% below its estimated fair value. The current FCF Yield % is 0.00. Integragen's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Integragen (XPAR:ALINT), the current FCF Yield % is 0.00 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integragen (XPAR:ALINT) Overvalued in 2026?
Based on GuruFocus' analysis, Integragen stock appears to be undervalued.
The current stock price of €0.19 is trading 55.7% below its estimated GF Value™ of €0.42.
GuruFocus considers Integragen to be Possible Value Trap.
Key valuation signals for XPAR:ALINT:
FCF Yield %: 0.00
GF Value™: €0.42 vs. price of €0.19 (55.7% below fair value)
No single metric tells the full story. See the XPAR:ALINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integragen is engaged in the development of genetic biomarkers. It offers genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics, and genomics news, as well as genomic research tools and solutions to microbiologic researchers.
29GF Score
Get the complete analysis for XPAR:ALINT
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALINT has been successfully added to your 
